147 related articles for article (PubMed ID: 10640590)
41. Evaluation of creams and ointments as suitable formulations for peldesine.
Viegas TX; Van Winkle LL; Lehman PA; Franz SF; Franz TJ
Int J Pharm; 2001 May; 219(1-2):73-80. PubMed ID: 11337167
[TBL] [Abstract][Full Text] [Related]
42. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil.
Mura S; Manconi M; Sinico C; Valenti D; Fadda AM
Int J Pharm; 2009 Oct; 380(1-2):72-9. PubMed ID: 19589377
[TBL] [Abstract][Full Text] [Related]
43. [Effect of enhancers on the permeation of ketoprofen in vitro].
Hu JH; Zhu Y
Yao Xue Xue Bao; 1996; 31(1):48-53. PubMed ID: 8762460
[TBL] [Abstract][Full Text] [Related]
44. Permeation Efficacy of a Transdermal Vehicle with Steroidal Hormones and Nonsteroidal Anti-inflammatory Agents as Model Drugs.
Junqueira LA; Polonini H; Loures S; Raposo NRB; Ferreira AO; Brandão MAF
Curr Drug Deliv; 2019; 16(2):136-141. PubMed ID: 30360741
[TBL] [Abstract][Full Text] [Related]
45. Ketoprofen-loaded polymer carriers in bigel formulation: an approach to enhancing drug photostability in topical application forms.
Andonova V; Peneva P; Georgiev GS; Toncheva VT; Apostolova E; Peychev Z; Dimitrova S; Katsarova M; Petrova N; Kassarova M
Int J Nanomedicine; 2017; 12():6221-6238. PubMed ID: 28894363
[TBL] [Abstract][Full Text] [Related]
46. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations.
El-Kattan AF; Asbill CS; Kim N; Michniak BB
Drug Deliv; 2000; 7(3):147-53. PubMed ID: 10989915
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of a new topical gel-spray formulation of ketoprofen lysine salt in the rat: percutaneous permeation in vitro and in vivo and pharmacological activity.
Porzio S; Caselli G; Pellegrini L; Pallottini V; Del Rosario M; Coppola A; Boltri L; Gentile M; Clavenna G; Melillo G
Pharmacol Res; 1998 Jan; 37(1):41-7. PubMed ID: 9503479
[TBL] [Abstract][Full Text] [Related]
48. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug.
Kim BS; Won M; Lee KM; Kim CS
Drug Deliv; 2008 Sep; 15(7):465-9. PubMed ID: 18712624
[TBL] [Abstract][Full Text] [Related]
49. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids.
Valenta C; Janisch M
Int J Pharm; 2003 Jun; 258(1-2):133-9. PubMed ID: 12753760
[TBL] [Abstract][Full Text] [Related]
50. Pluronic lecithin organogel as a topical drug delivery system.
Pandey M; Belgamwar V; Gattani S; Surana S; Tekade A
Drug Deliv; 2010 Jan; 17(1):38-47. PubMed ID: 22747074
[TBL] [Abstract][Full Text] [Related]
51. Peptide dendrimer-conjugates of ketoprofen: Synthesis and ex vivo and in vivo evaluations of passive diffusion, sonophoresis and iontophoresis for skin delivery.
Hegde AR; Rewatkar PV; Manikkath J; Tupally K; Parekh HS; Mutalik S
Eur J Pharm Sci; 2017 May; 102():237-249. PubMed ID: 28285173
[TBL] [Abstract][Full Text] [Related]
52. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers.
Cheng Y; Man N; Xu T; Fu R; Wang X; Wang X; Wen L
J Pharm Sci; 2007 Mar; 96(3):595-602. PubMed ID: 17094130
[TBL] [Abstract][Full Text] [Related]
53. Characterization and skin permeation of ketoprofen-loaded vesicular systems.
Uchino T; Lefeber F; Gooris G; Bouwstra J
Eur J Pharm Biopharm; 2014 Feb; 86(2):156-66. PubMed ID: 23500115
[TBL] [Abstract][Full Text] [Related]
54. Microemulsion: a novel transdermal delivery system to facilitate skin penetration of indomethacin.
Chen L; Tan F; Wang J; Liu F
Pharmazie; 2012 Apr; 67(4):319-23. PubMed ID: 22570938
[TBL] [Abstract][Full Text] [Related]
55. [Establishment and application of in situ perfused pig ear model for percutaneous absorption].
Hu JH; Zhu QG; Shen Q
Yao Xue Xue Bao; 2003 Oct; 38(10):783-6. PubMed ID: 14730905
[TBL] [Abstract][Full Text] [Related]
56. Transdermal Adhesive Patches Loaded with Ketoprofen Evaluated by Dynamic Detection of Percutaneous Absorption.
Wang M; Li L; Xie J; Sun Y; Ling G; He Z
AAPS PharmSciTech; 2017 Aug; 18(6):2141-2148. PubMed ID: 28035612
[TBL] [Abstract][Full Text] [Related]
57. Effect of sucrose fatty acid esters on transdermal permeation of lidocaine and ketoprofen.
Okamoto H; Sakai T; Danjo K
Biol Pharm Bull; 2005 Sep; 28(9):1689-94. PubMed ID: 16141541
[TBL] [Abstract][Full Text] [Related]
58. Optimisation of cosolvent concentration for topical drug delivery III--influence of lipophilic vehicles on ibuprofen permeation.
Watkinson RM; Guy RH; Oliveira G; Hadgraft J; Lane ME
Skin Pharmacol Physiol; 2011; 24(1):22-6. PubMed ID: 20616625
[TBL] [Abstract][Full Text] [Related]
59. Promoting mechanism of menthol derivative, 1-O-ethyl-3-buthylcyclohexanol, on the percutaneous absorption of ketoprofen.
Li CJ; Higashiyama K; Yoshimura Y; Nagai T; Takayama K; Obata Y
Biol Pharm Bull; 2001 Sep; 24(9):1044-8. PubMed ID: 11558566
[TBL] [Abstract][Full Text] [Related]
60. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
